|
1
|
Kamangar F, Dores GM and Anderson WF:
Patterns of cancer incidence, mortality, and prevalence across five
continents: Defining priorities to reduce cancer disparities in
different geographic regions of the world. J Clin Oncol.
24:2137–2150. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Shroff J, Thosani N, Batra S, Singh H and
Guha S: Reduced incidence and mortality from colorectal cancer with
flexible-sigmoidoscopy screening: A meta-analysis. World J
Gastroenterol. 20:18466–18476. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Chen W, Zheng R, Zeng H and Zhang S: The
updated incidences and mortalities of major cancers in China, 2011.
Chin J Cancer. 34:502–507. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Labianca R and Merelli B: Screening and
diagnosis for colorectal cancer: Present and future. Tumori.
96:889–901. 2010. View
Article : Google Scholar : PubMed/NCBI
|
|
5
|
Levi F, Lucchini F, Negri E, Zatonski W,
Boyle P and La Vecchia C: Trends in cancer mortality in the
European Union and accession countries, 1980–2000. Ann Oncol.
15:1425–1431. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Chouhan V, Mansoor E, Parasa S and Cooper
GS: Rates of prevalent colorectal cancer occurrence in persons 75
years of age and older: A population-based national study. Dig Dis
Sci. 63:1929–1936. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Kumar A, Cherukumilli M, Mahmoudpour SH,
Brand K and Bandapalli OR: ShRNA-mediated knock-down of CXCL8
inhibits tumor growth in colorectal liver metastasis. Biochem
Biophys Res Commun. 500:731–737. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Peng Y, Zhao BC, Kang Q, Liu J, Chen C, Li
BS, Xie YP and Wu Q: Colorectal cancer preventive effect of
combined administration of phenolic acids and supercritical
extracts from Angelica sinensis. Zhongguo Zhong Yao Za Zhi.
43:1235–1240. 2018.(In Chinese). PubMed/NCBI
|
|
9
|
Costa FF, Bischof JM, Vanin EF, Lulla RR,
Wang M, Sredni ST, Rajaram V, Bonaldo Mde F, Wang D, Goldman S, et
al: Identification of microRNAs as potential prognostic markers in
ependymoma. PLoS One. 6:e251142011. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Gattolliat CH, Thomas L, Ciafrè SA,
Meurice G, Le Teuff G, Job B, Richon C, Combaret V, Dessen P,
Valteau-Couanet D, et al: Expression of miR-487b and miR-410
encoded by 14q32.31 locus is a prognostic marker in neuroblastoma.
Br J Cancer. 105:1352–1361. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Haller F, von Heydebreck A, Zhang JD,
Gunawan B, Langer C, Ramadori G, Wiemann S and Sahin O:
Localization- and mutation-dependent microRNA (miRNA) expression
signatures in gastrointestinal stromal tumours (GISTs), with a
cluster of co-expressed miRNAs located at 14q32.31. J Pathol.
220:71–86. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Lavon I, Zrihan D, Granit A, Einstein O,
Fainstein N, Cohen MA, Cohen MA, Zelikovitch B, Shoshan Y, Spektor
S, et al: Gliomas display a microRNA expression profile reminiscent
of neural precursor cells. Neuro Oncol. 12:422–433. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Vasudevan S, Tong Y and Steitz JA:
Switching from repression to activation: microRNAs can up-regulate
translation. Science. 318:1931–1934. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Gong J, Zhang JP, Li B, Zeng C, You K,
Chen MX, Yuan Y and Zhuang SM: MicroRNA-125b promotes apoptosis by
regulating the expression of Mcl-1, Bcl-w and IL-6R. Oncogene.
32:3071–3079. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Corté H, Manceau G, Blons H and
Laurent-Puig P: MicroRNA and colorectal cancer. Dig Liver Dis.
44:195–200. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Wu N, Zhao X, Liu M, Liu H, Yao W, Zhang
Y, Cao S and Lin X: Role of microRNA-26b in glioma development and
its mediated regulation on EphA2. PLoS One. 6:e162642011.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Ai F, Zhang X, Li X, Qin Z, Ye Q, Tian L,
Tang A, Li N, Li G, Ma J and Shen S: Up-regulation of matrix
metalloproteinases in a mouse model of chemically induced
colitis-associated cancer: The role of microRNAs. Oncotarget.
6:5412–5425. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Takahashi Y, Iwaya T, Sawada G, Kurashige
J, Matsumura T, Uchi R, Ueo H, Takano Y, Eguchi H and Sudo T:
Up-regulation of NEK2 by MicroRNA-128 methylation is associated
with poor prognosis in colorectal cancer. Ann Surg Oncol.
21:205–212. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Cao Y, Pang H and Chen C: MicroRNA-128
inhibits invasion of colon cancer cells. Zhejiang Med J. 2016.(In
Chinese).
|
|
20
|
Ciafrè SA, Galardi S, Mangiola A, Ferracin
M, Liu CG, Sabatino G, Negrini M, Maira G, Croce CM and Farace MG:
Extensive modulation of a set of microRNAs in primary glioblastoma.
Biochem Biophys Res Commun. 334:1351–1358. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Tutar Y: miRNA and cancer; computational
and experimental approaches. Curr Pharm Biotechnol. 15:4292014.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Godlewski J, Nowicki MO, Bronisz A,
Williams S, Otsuki A, Nuovo G, Raychaudhury A, Newton HB, Chiocca
EA and Lawler S: Targeting of the Bmi-1 oncogene/stem cell renewal
factor by microRNA-128 inhibits glioma proliferation and
self-renewal. Cancer Res. 68:9125–9130. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Koulich E, Li X and DeMartino GN: Relative
structural and functional roles of multiple deubiquitylating
proteins associated with mammalian 26S proteasome. Mol Biol Cell.
19:1072–1082. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Fujita Y, Yagishita S, Takeshita F,
Yamamoto Y, Kuwano K and Ochiya T: Prognostic and therapeutic
impact of RPN2-mediated tumor malignancy in non-small-cell lung
cancer. Oncotarget. 6:3335–3345. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Honma K, Iwao-Koizumi K, Takeshita F,
Yamamoto Y, Yoshida T, Nishio K, Nagahara S, Kato K and Ochiya T:
RPN2 gene confers docetaxel resistance in breast cancer. Nat Med.
14:939–948. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Fujita Y, Takeshita F, Mizutani T, Ohgi T,
Kuwano K and Ochiya T: A novel platform to enable inhaled naked
RNAi medicine for lung cancer. Sci Rep. 3:33252013. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Takahashi RU, Takeshita F, Honma K, Ono M,
Kato K and Ochiya T: Ribophorin II regulates breast tumor
initiation and metastasis through the functional suppression of
GSK3β. Sci Rep. 3:24742013. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Zhao Y, Deng Y, Peng J, Sui Q, Lin J, Qiu
M and Pan Z: Does the preoperative prognostic nutritional index
predict survival in patients with liver metastases from colorectal
cancer who underwent curative resection? J Cancer. 9:2167–2174.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Hendricks A, Eggebrecht GL, Bernsmeier A,
Geisen R, Dall K, Trauzold A, Becker T, Kalthoff H, Schafmayer C,
Röder C and Hinz S: Identifying patients with an unfavorable
prognosis in early stages of colorectal carcinoma. Oncotarget.
9:27423–27434. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Han HQ, Liu T, Zhao LZ, Qi F and Wang PZ:
Clinical value of the sixth edition TNM stages analysing prognosis
of colorectal cancer. Zhonghua Yi Xue Za Zhi. 86:819–821. 2006.(In
Chinese). PubMed/NCBI
|
|
31
|
Chen JX, Tang XD, Xiang DB, Dong XL, Peng
FY and Sun GY: TNM stages and prognostic features of colorectal
mucinous adenocarcinomas: A meta analysis. Asian Pac J Cancer Prev.
13:3427–3430. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
D'Haene N, Fontanges Q, De Nève N,
Blanchard O, Melendez B, Delos M, Dehou MF, Maris C, Nagy N,
Rousseau E, et al: Clinical application of targeted next-generation
sequencing for colorectal cancer patients: A multicentric Belgian
experience. Oncotarget. 9:20761–20768. 2018.PubMed/NCBI
|
|
34
|
Sun J, Hu J, Wang G, Yang Z, Zhao C, Zhang
X and Wang J: LncRNA TUG1 promoted KIAA1199 expression via miR-600
to accelerate cell metastasis and epithelial-mesenchymal transition
in colorectal cancer. J Exp Clin Cancer Res. 37:1062018. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Feng H, Xu M, Zhang Y, Han B, Wang J and
Sun P: Identification of differentially expressed MicroRNAs
involved in the pathogenesis of colorectal cancer. Clin Lab.
64:797–804. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Li J, Xu J, Yan X, Jin K, Li W and Zhang
R: MicroRNA-485 plays tumour-suppressive roles in colorectal cancer
by directly targeting GAB2. Oncol Rep. 40:554–564. 2018.PubMed/NCBI
|
|
37
|
Sun W, Wang X, Li J, You C, Lu P, Feng H,
Kong Y, Zhang H, Liu Y, Jiao R, et al: MicroRNA-181a promotes
angiogenesis in colorectal cancer by targeting SRCIN1 to promote
the SRC/VEGF signaling pathway. Cell Death Dis. 9:4382018.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Zhang J, Yan B, Späth SS, Qun H, Cornelius
S, Guan D, Shao J, Hagiwara K, Van Waes C, Chen Z, et al:
Integrated transcriptional profiling and genomic analyses reveal
RPN2 and HMGB1 as promising biomarkers in colorectal cancer. Cell
Biosci. 5:532015. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Li H, Al-Japairai K, Tao Y and Xiang Z:
RPN2 promotes colorectal cancer cell proliferation through
modulating the glycosylation status of EGFR. Oncotarget.
8:72633–72651. 2017.PubMed/NCBI
|
|
40
|
Liu GL, Yang HJ, Liu B and Liu T: Effects
of microrna-19b on the proliferation, apoptosis, and migration of
Wilms' Tumor cells via the PTEN/PI3K/AKT signaling pathway. J Cell
Biochem. 118:3424–3434. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Lu X, Lv S, Mi Y, Wang L and Wang G:
Neuroprotective effect of miR-665 against sevoflurane
anesthesia-induced cognitive dysfunction in rats through PI3K/Akt
signaling pathway by targeting insulin-like growth factor 2. Am J
Transl Res. 9:1344–1356. 2017.PubMed/NCBI
|
|
42
|
Manning BD and Cantley LC: AKT/PKB
signaling: Navigating downstream. Cell. 129:1261–1274. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Liang J and Slingerland JM: Multiple roles
of the PI3K/PKB (Akt) pathway in cell cycle progression. Cell
Cycle. 2:339–345. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Liu Y, Bi T, Wang Z, Wu G, Qian L, Gao Q
and Shen G: Oxymatrine synergistically enhances antitumor activity
of oxaliplatin in colon carcinoma through PI3K/AKT/mTOR pathway.
Apoptosis. 21:1398–1407. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Sabe H: Cancer early dissemination:
Cancerous epithelial-mesenchymal transdifferentiation and
transforming growth factor beta signalling. J Biochem. 149:633–639.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Acloque H, Adams MS, Fishwick K,
Bronner-Fraser M and Nieto MA: Epithelial-mesenchymal transitions:
The importance of changing cell state in development and disease. J
Clin Invest. 119:1438–1449. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Gao H, Lan X, Li S and Xue Y:
Relationships of MMP-9, E-cadherin, and VEGF expression with
clinicopathological features and response to chemosensitivity in
gastric cancer. Tumour Biol. 39:10104283176983682017. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Visse R and Nagase H: Matrix
metalloproteinases and tissue inhibitors of metalloproteinases:
Structure, function, and biochemistry. Circ Res. 92:827–839. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Knapinska AM, Estrada CA and Fields GB:
The roles of matrix metalloproteinases in pancreatic cancer. Prog
Mol Biol Transl Sci. 148:339–354. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Parrish AR: Matrix metalloproteinases in
kidney disease: Role in pathogenesis and potential as a therapeutic
target. Prog Mol Biol Transl Sci. 148:31–65. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Curran S and Murray GI: Matrix
metalloproteinases: Molecular aspects of their roles in tumour
invasion and metastasis. Eur J Cancer. 36:1621–1630. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Hendrix AY and Kheradmand F: The role of
matrix metalloproteinases in development, repair, and destruction
of the lungs. Prog Mol Biol Transl Sci. 148:1–29. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Tang G, Du R, Tang Z and Kuang Y:
MiRNALet-7a mediates prostate cancer PC-3 cell invasion, migration
by inducing epithelial-mesenchymal transition through CCR7/MAPK
pathway. J Cell Biochem. 119:3725–3731. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Shang K, Bai YP, Wang C, Wang Z, Gu HY, Du
X, Zhou XY, Zheng CL, Chi YY, Mukaida N and Li YY: Crucial
involvement of tumor-associated neutrophils in the regulation of
chronic colitis-associated carcinogenesis in mice. PLoS One.
7:e518482012. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Cagatay Tuncay S, Cimen I, Savas B and
Banerjee S: MTA-1 expression is associated with metastasis and
epithelial to mesenchymal transition in colorectal cancer cells.
Tumor Biol. 34:1189–1204. 2013. View Article : Google Scholar
|
